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ABSTRACT
Objective: This study aimed to determine the decreased immune response of tuberculosis (TB) with diabetes mellitus (DM) patients.
Methods: A total of 105 TB patients who were undergoing treatment at health centers and hospitals in Banda Aceh and Aceh Besar were included in 
this study. Data collection was carried out by interviewed to obtained demographic and respondent categories based on the diagnosis. Measurements 
of height and weight were also conducted to obtain body mass index data. 5 mL peripheral blood was taken from each respondent group into a TB with 
DM (TB+DM) and TB without DM (TB-DM). The blood tested usage tumor necrosis factor-alpha (TNF-α) level using enzyme-linked immunosorbent 
assay and interferon-gamma (IFN-γ) using IFN-γ release assay.
Results: The average concentration of both TNF-α and IFN-γ was higher in TB-DM group (TNF-a 5.2 pg/mL; IFN-g 1.5 IU/mL) than in TB+DM group 
(TNF-a 2.06 pg/mL; IFN-g 2.86 IU/mL). There were significant differences in TNF-α between the two groups but no significant differences in IFN-γ 
protein concentration.
Conclusion: The immune response of TB patients with DM symptoms was markedly reduced by the decreased expression of TNF-α and IFN-γ.
Keywords: Tuberculosis, Diabetes mellitus, Tumor necrosis factor-alpha, Interferon-gamma.
INTRODUCTION
Pulmonary tuberculosis (TB) is an infectious disease caused by the 
bacterium Mycobacterium tuberculosis (M.tb). According to the WHO, in 
2017, 10 million people worldwide are infected with TB, while in 2018, 
RISKESDAS reported the prevalence of pulmonary TB in Indonesia 
reaches 0.4% and 0.5% in Aceh [1]. Diabetes mellitus (DM) is a lifetime 
chronic disease that can reduce the quality of life. The prevalence of DM 
patients in Aceh is around 1.68% [1]. People with DM may increase the 
risk of developing TB by 1.5 times as research conducted in Jakarta and 
Bandung showed that the prevalence of DM in TB patients was around 
17.1% and 11.6%, respectively [2].
The immune system responds to TB infection through tumor necrosis 
factor-alpha (TNF-α) and interferon-gamma (IFN-γ). Changes in the 
immune response also occur in people with DM, which will affect 
the susceptibility of DM patients accompanied by TB. Research 
by Lachamandes concluded that elevated blood glucose would 
increase TNF-α secretion in macrophages in TB patients. In addition, 
the phagocytosis ability of monocytes decreases on TB with DM 
(TB+DM) [3]. Meenakshi reported a study in India, where the production 
of IFN-γ was reduced in the TB group with DM [4]. In contrast, Kumar 
et al. showed the increased expression of CD4 in the IFN-γ-secreting T 
cells in TB patients with DM [5].
Aceh is one of the provinces in Indonesia, which has a high proportion 
number of TB and DM, andthis factor increases the difficulty of 
breaking the chain of TB contagious. The high rate of DM causes the 
possibility of individuals to be more susceptible to TB. The aim of 
this research is to observe the dynamic of an immune response in DM 
patients, which may contribute to the susceptibility of TB infection in 
Aceh Province.
METHODS
This research did 6 months in Banda Aceh and Aceh Besar. The samples 
in this study were patients with TB that treated in health centers in 
Banda Aceh and Aceh Besar in 2018. Samples of the study included 
105 people who were willing to take part in the study (signed informed 
consent). Samples consisted of 55 people having TB without DM 
(TB-DM), 51 people having TB+DM. DM diagnosis determined based 
on the results of the HbA1c examination ≥6.5%. This study received 
ethics approval from the Health Research Ethics Commission, Health 
Research, and Development Agency No: LB.02.01/KE.162/2018.
Data collection carried out by interviewed to obtained demographic 
data and respondent categories data based on the diagnosis; 
measurement height and weight to got body mass index (BMI) data; 
and laboratory check to obtained a protein concentration of TNF-α and 
proteins IFN-γ serum.
The examination of TNF-α protein was conducted by the usage of the 
enzyme-linked immunosorbent assay (ELISA) sandwich test that used 
human TNF-α ELISA kit with product catalog number E-EL-H0109. 
A total of 100 µL of the serum added to the ELISA well, then incubated 
for 90 min at 37°C. After the liquid had been removed, 100 µL 
biotinylated detection Ab added and incubated for 1 h at 37°C. Then, 
it washed with wash buffer and added 100 µL horseradish peroxidase 
conjugate working solution and incubated for 30 min at 37°C. After the 
solution had been removed and washed, added 90 µL to the substrate 
and incubated for 15 min at 37°C. Then, a stop solution was added, and 
the results were read at a wavelength of 450 nm.
The examination of the protein concentration of IFN-γ was performed 
by usage the IFN-γ release assay (IGRA) with Quantiferon TB Gold Plus 
(QFT-Plus) blood collection tubes (product catalog number 004 716 
361) and Quantiferon AKS-TB Gold Plus (QFT-Plus) 2 plate ELISA kit 
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(product catalog numbers AKS-004716074). A total of 1 mL of blood 
was put into the four IGRA test tubes that named nil tube, TB1, TB2, 
and mitogen tubes, and then incubated for 24 h at 37°C. Furthermore, 
plasma is separated from blood cells and followed by ELISA test. A total 
of 50 µL working strength conjugate was put into the ELISA well and 
50 µL of sample or standard solution added and incubated for 120 min 
at 22°C. Then, the samples washed as much as 6 times, and 100 μL of 
the substrate was added and incubated for 30 min at 22°C. Finally, a 
50 µL stop solution is added, and the results are read at a wavelength 
of 450 nm.
SPSS version 23 usage for analysis, univariate analysis performed 
to determine the categories of respondents based on the diagnosis. 
Bivariate analysis (Chi-square test and Mann–Whitney test) was also 
undertaken to examine the relationship between demographic status 
with the condition of DM in TB patients and differences in the averaged 
concentration of TNF-α and IFN-γ in the TB+DM group with TB-DM. 
The significance value was p<0.05.
RESULTS
This study included 105 respondents, with the dominant gender was 
male. For the TB+DM group, most respondents were in the age range 
between 46 and 60 years, while in the TD-DM group, most were in the 
age range between 31 and 45 years. Therefore, based on the Chi-square 
test, there were significant differences in age between the two groups. 
The education level of most respondents in both groups was a high 
school graduated, and most respondents in both groups did not work. 
The BMI of most respondents in the TB+DM group was 18.5–25, while 
the TB-DM group was <18.5, so based on the Chi-square test there were 
significant differences between the two groups (Table 1).
Table 1: Relationship between demographic status and the 
occurrence of DM in TB patients
Variables TB with DM p-value
Yes No
F % F %
Gender 0.307
Male 36 34.3 32 30.5
Female 15 14.3 22 21.0
Age (years) 0.019
≤30 3 2.9 13 12.4
31–45 14 13.3 19 18.1
46–60 26 24.8 15 14.3
>61 8 7.6 7 6.7
Education 0.694
Never did school 2 1.9 1 1.0
Not graduated elementary 
school
6 5.7 5 4.8
Graduated elementary 
school
12 11.4 9 8.6
Graduated middle school 12 11.4 10 9.5
Graduated high school 15 14.3 23 21.9
Graduated university, 
master degree, doctoral 
degree
4 3.8 6 5.7
Work 0.43
Does not work 13 12.4 22 21.0
Farmer 7 6.7 3 2.9
Labor 8 7.6 6 5.7
Trader 6 5.7 4 3.8
Non-government/
government employee
9 8.6 8 7.6
Others 8 7.6 11 10.5
BMI 0.027
<18.5 14 13.3 28 26.7
18.5–25 28 26.7 22 21.0
>25 9 8.6 4 3.8
DM: Diabetes mellitus, TB: Tuberculosis, BMI: Body mass index
Among TB+DM respondents, most suffered DM previous and then 
become infected by TB. For respondents who suffered TB, the period 
of TB to the diagnosis of DM is 0–5 years. For respondents who were 
diagnosed with diabetes first, the period for most respondents until 
they were diagnosed with TB were 0–5 years. Most respondents in this 
category are patients. Respondents who were diagnosed with TB in the 
same year as DM were respondents who did not know that they had 
been sick with DM before. The diagnosis of DM is made by examining 
HbA1c, and most respondents in this category are also new patients 
(Table 2).
TNF-α test to determine protein concentration was carried out by 
the ELISA sandwich test, and the protein concentration found with a 
standard curve.
Fig. 1 illustrated the distribution pattern of TNF-α protein concentration 
found in serum from respondents suffering TB-DM and TB+DM. 
Mann–Whitney test was performed to determine the difference in the 
average TNF-α protein concentration in the two groups. Moreover, it 
was found that there were most significant differences in TNF-α protein 
concentration serum between the TB-DM group and TB+DM. TB-DM 
group had averaged of TNF-α protein concentration serum was higher 
than TB+DM group (Table 3).
Fig. 2 illustrated the distribution of IFN-γ plasma proteins concentration 
on the TB-DM group and TB+DM group. After the Mann–Whitney 
test conducted, there are no significant differences in IFN-γ protein 




0–5 years 2 3.9
6–10 years 0 0.0
11–15 years 0 0.0
>15 years 0 0.0 
Categories
New patient 1 2.0 
Relapsed patient 1 2.0 
Dropped of medication patient 0 0.0
DM first (n=28)
Range of years
0–5 years 17 33.3
6–10 years 7 13.7
11–15 years 1 2.0
>15 years 3 5.9
Categories
New patient 26 51.0
Relapsed patient 2 3.9
Dropped of medication patient 0 0.0
Diagnosed in the same year (n=21)
Categories
New patient 17 33.3
Relapsed patient 1 2.0
Dropped of medication patient 3 5.9
DM: Diabetes mellitus, TB: Tuberculosis
Table 3: Concentrations of TNF-α (pg/mL) and IFN-γ (IU/mL) in 
TB-DM and TB+DM
Mean (min-max) Standard deviation p-value
TNF-α
TB-DM 5.2 (0.1–14) 3.486 0.00
TB+DM 2.06 (0.1–7.4) 1.979
IFN-γ
TB-DM 1.5 (0.02–7.72) 1.83 0.727
TB+DM 1.3 (0.05–4.45) 1.404
TNF-α: Tumor necrosis factor-alpha, IFN-γ: Interferon-gamma, DM: Diabetes 
mellitus, TB: Tuberculosis
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concentration between the two groups. However, TB-DM group had 
averaged of IFN-γ protein concentration was higher than TB+DM group 
(Table 3).
DISCUSSION
TB still a serious threat to public health. A study conducted by Zin et al. 
revealed that male aged 20–59 years more often infected by TB [6]. 
Research conducted by Fahmi in TB+DM cases, male also become the 
dominant sufferers, with most was <30 years old [7]. This study also 
found that male had more TB, both the TB+DM and TB-DM groups, but 
did not affect the occurrence of TB+DM. Age range 46–60 years more 
had susceptible TB+DM; whereas, in the TB-DM group, age 31–45 years 
had most. This age range difference had affected to the TB+DM 
condition. Harso et al. and Illahi et al. mentioned similar results that the 
age of 45–54 years was more susceptible to had TB+DM, and the age 
range of 25–34 years had TB-DM [8,9]. In addition, Arlinda indicated 
similar results [10]. Thus, we proposed that age can be classified as a 
risk factor of having TB+DM.
For education level categories, most of the respondents were high 
school graduated but did not affect the occurrence of TB+DM cases. 
The same result was obtained by Harso et al. that the level of education 
graduated from high school was more dominant in both groups [8]. 
Most respondents did not have permanent jobs and work also did not 
affect to TB+DM cases. This discovery is different from what by Fahmi 
mentioned that most TB patients had jobs [7]. Based on BMI data, we 
found that most of the respondents had a normal BMI data for both 
groups, and there is a significant difference in BMI data between the 
two groups.
DM patients are more susceptible to suffering TB. This study 
demonstrated that most TB patients had already suffered from 
diabetes. This discovery is according to a research by Hayashi and 
Chandramohan who conducted a meta-analysis of 14 studies [11]. Most 
respondents had a period of 0–5 years from being diagnosed with DM 
to being diagnosed with TB and are new TB patients.
The results also found that many respondents were diagnosed with TB 
and DM in the same year. This can happen because the respondent did 
not know that they had DM. This case instigated by the symptomatic 
illness lead to patients did not come to the health centers. Moreover, 
the patients had a low interest to conducted regular health check-up 
to detect the disease sooner. Acknowledgment of DM disease caused 
them did not received treatment for blood glucose control. Immunity 
impaired in DM sufferers made it more susceptible to TB disease [5].
The immune response against M.tb is mediated by cytokines and 
Th1 cells, which contributes in eliminating microbacterial infection. 
IFN-γ is the main cytokine that was involved in the immune response 
against micro bacteria. Its main function is the activation of macrophage, 
allowing them to exert the microbicidal function. TNF-α has a primordial 
function to synergize with IFN-γ, stimulating the production of reactive 
nitrogen intermediates. It will mediate the function of tuberculostatic 
macrophages, stimulates the migration of immune cells to the location 
of the infection, and contributes to the formation of granulomas [12].
DM in patients with pulmonary TB causes failure in treatment and 
worsens the disease compared to pulmonary TB-DM. The rifampicin 
serum concentration in hyperglycemia patients was found lower 
also [13]. Researches that have been done about the related between 
DM and TB showed that DM was an important risk main factor in the 
developed of TB. Increased risk and severity of TB disease, DM had a 
significant negative impacted on public health, especially in countries 
where both conditions were common. According the complexity of the 
diabetes complications mechanism and the many things involved, the 
possibility of an immune responded to M.tb infection was affected at 
many levels [14].
Pulmonary TB disease with diabetes was signed by an increased 
cytokine responded that indicated the presence of chronic inflammation 
that underlies type 2 diabetes. This had the potential to increased 
immune pathology and poor control in pulmonary TB infection [5]. 
The effector function for bacterial elimination was mediated by 
macrophages activated by cytokines derived from T lymphocytes, 
specifically IFN-γ, and TNF-α [12].
The results presented in Fig. 1. was showed that TNF-α concentration 
in serum was lower in TB with DM group. It was indicated that the 
responded of the immune body on a group of TB-DM was much better 
than on a group of TB+DM. Similar results revealed by Cheekatla 
et al., who researched mice [15]. However, a different result was stated 
by Raposo-García et al. that said there was an increased in TNF-α 
production in M.tb infected blood on patients with DM [16]. A causes by 
Fig. 1: (a and b) Distribution of tumor necrosis factor-alpha protein concentations in tuberculosis without diabetes mellitus group and 
TB+DM group
Fig. 2: (a and b) Distribution of the concentration interferon-gamma proteins concentations in tuberculosis without diabetes mellitus 
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different results in this research were the blood sample that was usage 
from patients with diabetes that incubated with M.tb. The result was 
also different from research by Lachmandas et al. that conducted the 
research in vitro using peripheral blood mononuclear cells from healthy 
individual [3].
Fig. 2. shows that there were no significant differences in the IFN-γ 
protein concentration between the two groups, but the average of TB-DM 
was higher than TB+DM. The same result was also revealed by Kumar 
et al. In the TB-DM group, there was an increased in IFN-γ compared 
to the TB-DM group [17]. Other research showed a similar condition 
that there was an impaired of immune response in DM patients with 
hyperglycemia, as marked by an increase of IFN-γ concentration, and 
caused the changes in the regulation of cytokine Th1 that was created 
by the increased of the protein end product [18].
Our result showed a decreased in the immune response in patients 
with TB+DM. The impaired immune response will compromise the 
body’s defense system to fight TB infection. This might explain the high 
number of TB disease in DM patients.
CONCLUSION
A declined in the immune response of TB patients with DM was marked 
by the decreased of TNF-α and IFN-γ protein expression. This decreased 
in immune responded might led to the DM patients more susceptible to 
suffered TB.
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